Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Operations (2021 - 2025)

Historic Cash from Operations for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$2.6 million.

  • MDxHealth's Cash from Operations rose 5663.16% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year increase of 6534.97%. This contributed to the annual value of -$53.9 million for FY2024, which is 9729.21% down from last year.
  • As of Q3 2025, MDxHealth's Cash from Operations stood at -$2.6 million, which was up 5663.16% from -$1.9 million recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Cash from Operations peaked at $24.9 million during Q2 2022, and registered a low of -$17.7 million during Q2 2023.
  • Its 5-year average for Cash from Operations is -$2.9 million, with a median of -$6.1 million in 2024.
  • Examining YoY changes over the last 5 years, MDxHealth's Cash from Operations showed a top increase of 21101.63% in 2023 and a maximum decrease of 17128.84% in 2023.
  • Over the past 5 years, MDxHealth's Cash from Operations (Quarter) stood at -$7.2 million in 2021, then decreased by 23.46% to -$8.9 million in 2022, then increased by 29.52% to -$6.3 million in 2023, then rose by 26.93% to -$4.6 million in 2024, then soared by 42.66% to -$2.6 million in 2025.
  • Its Cash from Operations was -$2.6 million in Q3 2025, compared to -$1.9 million in Q2 2025 and $4.6 million in Q1 2025.